These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9665256)

  • 21. Botulinum toxin for treatment of dystonia.
    Dressler D
    Eur J Neurol; 2010 Jul; 17 Suppl 1():88-96. PubMed ID: 20590814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [First use of botulinum toxin type B in ENT patients with secondary therapy failure of botulinum toxin type A].
    Guntinas-Lichius O
    HNO; 2004 Jan; 52(1):53-6. PubMed ID: 14740116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laryngeal Botulinum Toxin Injection for Vocal Tremor: Utility of Concurrent Strap Muscle Injection.
    Nelson RC; Silva Merea V; Tierney WS; Milstein C; Benninger MS; Bryson PC
    Laryngoscope; 2019 Jun; 129(6):1433-1437. PubMed ID: 30588631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin injection and airflow stability in spasmodic dysphonia.
    Cantarella G; Berlusconi A; Maraschi B; Ghio A; Barbieri S
    Otolaryngol Head Neck Surg; 2006 Mar; 134(3):419-23. PubMed ID: 16500438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased stability of airflow following botulinum toxin injection.
    Finnegan EM; Luschei ES; Gordon JD; Barkmeier JM; Hoffman HT
    Laryngoscope; 1999 Aug; 109(8):1300-6. PubMed ID: 10443837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to botulinum toxin injections for spasmodic dysphonia.
    Smith ME; Ford CN
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):533-5. PubMed ID: 10772310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin in motor disorders: practical considerations with emphasis on interventional neurophysiology.
    Traba López A; Esteban A
    Neurophysiol Clin; 2001 Aug; 31(4):220-9. PubMed ID: 11596529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
    Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
    Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of botulinum toxin type A injection on compound muscle action potential in an in vivo rat model.
    Cichon JV; McCaffrey TV; Litchy WJ; Knops JL
    Laryngoscope; 1995 Feb; 105(2):144-8. PubMed ID: 8544593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
    Davidson BJ; Ludlow CL
    Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
    Ludlow CL; Naunton RF; Fujita M; Sedory SE
    Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of laryngeal resistance in the evaluation of botulinum toxin injection for treatment of focal laryngeal dystonia.
    Witsell DL; Weissler MC; Donovan MK; Howard JF; Martinkosky SJ
    Laryngoscope; 1994 Jan; 104(1 Pt 1):8-11. PubMed ID: 8295461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histology of nerves and muscles in adductor spasmodic dysphonia.
    Chhetri DK; Blumin JH; Vinters HV; Berke GS
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle.
    Maronian NC; Waugh PF; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin therapy for blepharospasm in the otolaryngology clinic.
    Lassen LF; Adams J
    ORL Head Neck Nurs; 1994; 12(3):12-3. PubMed ID: 8564763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
    Holzer SE; Ludlow CL
    Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of cricothyroid and thyroarytenoid muscle botulinum toxin injection on patients with dyspnea caused by bilateral recurrent laryngeal nerve paresis].
    Xu XL; Lai JM; Qiu T; Ma YL; Jiao YC; Zhuang PY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):375-380. PubMed ID: 29764020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.